Balentine LLC’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Balentine LLC’s Portfolio SYNH Stock Details SYNH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-420	Closed	-$25K	–	662
2017 Q2	$25K	Sell	420 -100	-19%	-$5.2K	﹤0.01%	341
2017 Q1	$24K	Hold	520	–	–	﹤0.01%	325
2016 Q4	$27K	Buy	520 +140	+37%	+$6.78K	﹤0.01%	279
2016 Q3	$17K	Hold	380	–	–	﹤0.01%	297
2016 Q2	$14K	Buy	380 +40	+12%	+$1.76K	﹤0.01%	297
2016 Q1	$14K	Buy	340 +30	+10%	+$1.24K	﹤0.01%	216
2015 Q4	$15K	Buy	310 +40	+15%	+$1.78K	﹤0.01%	281
2015 Q3	$11K	Hold	270	–	–	﹤0.01%	344
2015 Q2	$11K	Buy	+270	New	+$9.31K	﹤0.01%	318

Other funds holding SYNH

THLTP

Thomas H. Lee (THL) Partners Boston, Massachusetts $205M AUM 1.84% 1-Year Est. Return

Advent International Boston, Massachusetts $4.24B AUM 4.24% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Balentine LLC's SYNH Position: Q3 2017 in Review

Balentine LLC sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q3 2017, closing a stake of 420 shares — an estimated $25K sold.

Balentine LLC first reported a position in SYNH in Q2 2015 and held it in 9 quarters. The position peaked at $27K in Q4 2016. 238 funds tracked by Wall St. Rank hold SYNH as of Q3 2017.

Balentine LLC reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q3 2017 after selling out during the quarter.
Balentine LLC sold 420 Syneos Health, Inc. Class A Common Stock shares in Q3 2017, an estimated $25K.
Balentine LLC first reported a position in Syneos Health, Inc. Class A Common Stock in Q2 2015 and held it in 9 quarters.
Balentine LLC's Syneos Health, Inc. Class A Common Stock position peaked at $27K in Q4 2016.
238 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q3 2017.

Based on Balentine LLC's 13F filing for Q3 2017, filed 15 Nov 2017.